Airway fibrin formation cascade in allergic asthma exacerbation: implications for inflammation and remodeling

[1]  Kevin D. Moss,et al.  Fibrin is a critical regulator of neutrophil effector function at the oral mucosal barrier , 2021, Science.

[2]  J. Ingram,et al.  Imbalanced Coagulation in the Airway of Type-2 High Asthma with Comorbid Obesity , 2021, Journal of asthma and allergy.

[3]  N. Jarjour,et al.  Interleukin-1α Is a Critical Mediator of the Response of Human Bronchial Fibroblasts to Eosinophilic Inflammation , 2021, Cells.

[4]  N. Jarjour,et al.  Increased IL‐6 and Potential IL‐6 trans‐signalling in the airways after an allergen challenge , 2021, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[5]  Kyle A. Brown,et al.  High-throughput Proteomics Enabled by a Photocleavable Surfactant. , 2020, Angewandte Chemie.

[6]  G. Maksym,et al.  Defective Fibrillar Collagen Organization by Fibroblasts Contributes to Airway Remodeling in Asthma. , 2019, American journal of respiratory and critical care medicine.

[7]  W. Calhoun,et al.  Pharmacoproteomics reveal novel protective activity of bromodomain containing 4 inhibitors on vascular homeostasis in TLR3-mediated airway remodeling. , 2019, Journal of proteomics.

[8]  Kenneth R. Jeffries,et al.  Apolipoprotein E is a concentration-dependent pulmonary danger signal that activates the NLRP3 inflammasome and IL-1β secretion by bronchoalveolar fluid macrophages from asthmatic subjects. , 2019, The Journal of allergy and clinical immunology.

[9]  Roman Fischer,et al.  MaxQuant Software for Ion Mobility Enhanced Shotgun Proteomics* , 2019, Molecular & Cellular Proteomics.

[10]  W. Calhoun,et al.  Mucosal bromodomain‐containing protein 4 mediates aeroallergen‐induced inflammation and remodeling , 2019, The Journal of allergy and clinical immunology.

[11]  Ying Ge,et al.  A photo-cleavable surfactant for top-down proteomics , 2019, Nature Methods.

[12]  E. Hoffman,et al.  Mucus plugs in patients with asthma linked to eosinophilia and airflow obstruction , 2018, The Journal of clinical investigation.

[13]  Lin Ying Liu,et al.  Mepolizumab Attenuates Airway Eosinophil Numbers, but Not Their Functional Phenotype, in Asthma , 2017, American journal of respiratory and critical care medicine.

[14]  Marco Y. Hein,et al.  The Perseus computational platform for comprehensive analysis of (prote)omics data , 2016, Nature Methods.

[15]  N. Jarjour,et al.  Segmental allergen challenge increases levels of airway follistatin-like 1 in patients with asthma. , 2016, The Journal of allergy and clinical immunology.

[16]  L. Mastalerz,et al.  Asthma is associated with enhanced thrombin formation and impaired fibrinolysis , 2016, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[17]  W. Busse,et al.  Airway factor XIII associates with type 2 inflammation and airway obstruction in asthmatic patients. , 2016, The Journal of allergy and clinical immunology.

[18]  T. Omachi,et al.  Asthma exacerbations and lung function in patients with severe or difficult-to-treat asthma. , 2015, The Journal of allergy and clinical immunology.

[19]  C. Corrigan,et al.  Resistin‐like molecule‐β (RELM‐β) targets airways fibroblasts to effect remodelling in asthma: from mouse to man , 2015, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[20]  S. R. Reeves,et al.  Asthmatic airway epithelial cells differentially regulate fibroblast expression of extracellular matrix components. , 2014, The Journal of allergy and clinical immunology.

[21]  J. Wiktorowicz,et al.  Proteomic analysis of the asthmatic airway. , 2014, Advances in experimental medicine and biology.

[22]  A. Brasier.  Heterogeneity in Asthma , 2014, Advances in Experimental Medicine and Biology.

[23]  N. Jarjour,et al.  Anti‐IL‐5 attenuates activation and surface density of β2‐integrins on circulating eosinophils after segmental antigen challenge , 2013, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[24]  M. Gavala,et al.  Segmental allergen challenge enhances chitinase activity and levels of CCL18 in mild atopic asthma , 2013, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[25]  A. Carter,et al.  Substrates of Factor XIII-A: roles in thrombosis and wound healing. , 2013, Clinical science.

[26]  N. Jarjour,et al.  Safety of and Cellular Response to Segmental Bronchoprovocation in Allergic Asthma , 2013, PloS one.

[27]  T. van der Poll,et al.  Asthma and coagulation. , 2012, Blood.

[28]  T. Scott,et al.  Discovery Proteomics and Nonparametric Modeling Pipeline in the Development of a Candidate Biomarker Panel for Dengue Hemorrhagic Fever , 2012, Clinical and translational science.

[29]  Q. Hamid,et al.  Remodeling in asthma. , 2011, The Journal of allergy and clinical immunology.

[30]  D. Postma,et al.  E-cadherin gene polymorphisms in asthma patients using inhaled corticosteroids , 2011, European Respiratory Journal.

[31]  N. Raghavachari,et al.  Apolipoprotein E negatively regulates house dust mite-induced asthma via a low-density lipoprotein receptor-mediated pathway. , 2010, American journal of respiratory and critical care medicine.

[32]  J. Shute,et al.  Up-regulation of the Extrinsic Coagulation Pathway in Acute Asthma—A Case Study , 2010, The Journal of asthma : official journal of the Association for the Care of Asthma.

[33]  Q. Hamid,et al.  Airway remodelling in asthma: from benchside to clinical practice. , 2010, Canadian respiratory journal.

[34]  T. Goldmann,et al.  Expression of the acute phase protein haptoglobin in human lung cancer and tumor-free lung tissues. , 2009, Pathology, research and practice.

[35]  J. Shute,et al.  Coagulation factors in the airways in moderate and severe asthma and the effect of inhaled steroids , 2009, Thorax.

[36]  K. Huntoon,et al.  The acute phase protein haptoglobin regulates host immunity , 2008, Journal of leukocyte biology.

[37]  P. Gibson,et al.  Asthma exacerbations · 3: Pathogenesis , 2006, Thorax.

[38]  G. Marko‐Varga,et al.  Specific haptoglobin expression in bronchoalveolar lavage during differentiation of circulating fibroblast progenitor cells in mild asthma. , 2006, Journal of proteome research.

[39]  W. Busse,et al.  Enhanced generation of helper T type 1 and 2 chemokines in allergen-induced asthma. , 2004, American journal of respiratory and critical care medicine.

[40]  Lauren Cohn,et al.  Asthma: mechanisms of disease persistence and progression. , 2004, Annual review of immunology.

[41]  N. Jarjour,et al.  Increased thrombin activity after allergen challenge: a potential link to airway remodeling? , 2004, American journal of respiratory and critical care medicine.

[42]  S. Idell.  Coagulation, fibrinolysis, and fibrin deposition in acute lung injury , 2003, Critical care medicine.

[43]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[44]  Q. Hamid,et al.  Inflammatory cells in asthma: mechanisms and implications for therapy. , 2003, The Journal of allergy and clinical immunology.

[45]  R. Gibson,et al.  Plastic bronchitis in children: A case series and review of the medical literature , 2002, Pediatric pulmonology.

[46]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[47]  W. Busse,et al.  Increased matrix metalloproteinase-9 in the airway after allergen challenge. , 2000, American journal of respiratory and critical care medicine.

[48]  W. Busse,et al.  Segmental antigen challenge increases fibronectin in bronchoalveolar lavage fluid. , 1999, American journal of respiratory and critical care medicine.

[49]  M. Ebina,et al.  Marked goblet cell hyperplasia with mucus accumulation in the airways of patients who died of severe acute asthma attack. , 1992, Chest.